Shiao-Pei Weathers - Concepedia

Author

Shiao-Pei Weathers

The University of Texas MD Anderson Cancer Center

Also Known As

S Weathers, S.-P. Weathers, Shiao-Pei Weathers

Publications

923

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center National Institutes of Health Caris Life Sciences (United States)

About

Shiao-Pei Weathers is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cancer therapeutics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	273
2	Neurology	2	2	86
3	Pathology	2	2	209
4	Cellular Therapies	1	1	22
5	Immunology	1	1	22

Shiao-Pei Weathers

Publications

776

Citations

H-Index

Page 1

	Year	Citations
Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201 S. Andrew, Rohinton S. Tarapore, Matthew D. Hall, Journal of Neuro-Oncology Neuro-oncologyTumor BiologyMedicinePharmacologyPathology	2019	187
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages John de Groot, Marta Peñas-Prado, Kristin Alfaro-Munoz, Neuro-Oncology	2019	158
Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies Sarah T. Garber, Yuuri Hashimoto, Shiao-Pei Weathers, Neuro-Oncology	2016	138
A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma Shiao-Pei Weathers, Xiaosi Han, Diane D. Liu, Journal of Neuro-Oncology Neuro-oncologyLow Dose BevacizumabMedicineStandard Dose BevacizumabMetronomic Therapy	2016	64
Pilot randomized, controlled trial of a dyadic yoga program for glioma patients undergoing radiotherapy and their family caregivers Kathrin Milbury, Jing Li, Shiao-Pei Weathers, Neuro-Oncology Practice	2018	55
Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial Shiao-Pei Weathers, Marta Penas‐Prado, Be-Lian Pei, Clinical Cancer Research	2020	46
GBM-associated mutations and altered protein expression are more common in young patients Sherise D. Ferguson, Joanne Xiu, Shiao-Pei Weathers, Oncotarget	2016	32
Management of a patient with mantle cell lymphoma who developed severe neurotoxicity after chimeric antigen receptor T-cell therapy in ZUMA-2 Michael Wang, Preetesh Jain, Sheree E Chen, Journal for ImmunoTherapy of Cancer Cell TherapyImmunologyPathologyCell DeathImmunotherapy	2020	22
Prospective Clinical Sequencing of Adult Glioma Siyuan Zheng, Kristin Alfaro-Munoz, Wei Wei, Molecular Cancer Therapeutics	2019	21
Pre-surgical connectome features predict IDH status in diffuse gliomas Shelli R. Kesler, Rebecca A. Harrison, Melissa Petersen, Oncotarget	2019	21

Page 1